RT Journal Article SR Electronic T1 Multi-cohort transcriptomic subtyping of B-cell acute lymphoblastic leukemia JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.02.17.22270919 DO 10.1101/2022.02.17.22270919 A1 Mäkinen, Ville-Petteri A1 Rehn, Jacqueline A1 Breen, James A1 Yeung, David A1 White, Deborah L YR 2022 UL http://medrxiv.org/content/early/2022/02/19/2022.02.17.22270919.abstract AB Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and comprises multiple genetically distinguishable subtypes. To detect subtypes, current pipelines include fusion calling, polymorphisms, candidate gene copy numbers and cytogenetics but these approaches have limitations. RNA-seq provides a functional genome-wide snapshot that enables classification of ALL subtypes, however, typical mRNA-seq clustering analyses lack the rigor of quantitative modelling. Furthermore, high-dimensional gene expression data across cohorts and countries contain biases that previous transcriptomics studies have not addressed. Our aim was to integrate easy-to-interpret reliable transcriptome-wide biomarkers into subtyping pipelines. We analyzed 2,046 samples from two continents, carefully adjusted for biases and applied a rigorous machine learning design with independent replication. Six ALL subtypes that covered 32% of patients were robustly detected by mRNA-seq (PPV ≥ 87%). Five other frequent subtypes were distinguishable in 40% of patients, although overlapping transcriptional profiles led to lower accuracy (52% ≤ PPV ≤ 73%). Based on these findings, we developed the Allspice tool that predicts ALL subtypes and driver genes from unadjusted mRNA-seq read counts as encountered in real-world settings. Allspice also includes quantitative classification and safety metrics to help determine the most plausible genetic drivers for cases where other findings are inconclusive.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDLW was funded by the National Health and Medical Research Council of Australia Target Call for Research and by Cancer Council Beat Cancer Project. The work was also supported by Australasian Leukaemia and Lymphoma Group and Australian and New Zealand Children's Haematology/Oncology Group.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committees at the Royal Adelaide Hospital and the Central Adelaide Local Health Network gave ethical approval for the analyses.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe North American mRNA-seq data files are available in the European Genome-Phenome Archive (EGAD00001004461 and EGAD00001004463). The Australian dataset is available from the authors upon request. https://ega-archive.org/datasets/EGAD00001004461 https://ega-archive.org/datasets/EGAD00001004463 https://gtexportal.org/home/datasets https://www.ebi.ac.uk/arrayexpress/experiments/E-GEUV-1/files/analysis_results/